Solu-medrol Injection, Powder, For Solution
NDC Package 51662-1264-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Solu-medrol injection is a medication used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. This formulation utilizes a injection, powder, for solution delivery system. Marketed by Hf Acquisition Co. Llc, Dba Healthfirst, this product is identified by NDC 51662-1264 and is authorized under FDA application NDA011856.

Identification & Billing

NDC Package Code
51662-1264-3
Package Description
25 POUCH in 1 CASE / 1 mL in 1 POUCH (51662-1264-2)
Product Code
51662-1264
11-Digit Billing Format
51662126403
RxNorm Crosswalk
  • RxCUI: 311659 - methylPREDNISolone sodium succinate 40 MG Injection
  • RxCUI: 311659 - methylprednisolone 40 MG Injection
  • RxCUI: 311659 - methylprednisolone (as methylprednisolone sodium succinate) 40 MG Injection

Clinical Specifications

Proprietary Name
Solu-medrol
Non-Proprietary Name
Solu-medrol
Substance Name
Methylprednisolone Sodium Succinate
Dosage Form
Injection, Powder, For Solution - A sterile preparation intended for reconstitution to form a solution for parenteral use.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
METHYLPREDNISOLONE SODIUM SUCCINATE 40 mg/mL
Pharmacologic Class
Usage Information
This medication is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. Methylprednisolone is a corticosteroid hormone. This injectable form of methylprednisolone is used when a similar drug cannot be taken by mouth or when a very fast response is needed, especially in patients with severe medical conditions. Talk to your doctor about the risks and benefits of methylprednisolone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use. Methylprednisolone may also be used with other medications in hormone disorders.

Regulatory & Marketing

Labeler Name
Hf Acquisition Co. Llc, Dba Healthfirst
Product Type
Human Prescription Drug
FDA Application #
NDA011856
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
09-02-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (51662-1264). Click a package code to view its specific billing and regulatory data.

51662-1264-1
1 mL in 1 VIAL, SINGLE-DOSE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51662-1264-3 identifies a specific commercial package of 25 pouch in 1 case / 1 ml in 1 pouch (51662-1264-2) of Solu-medrol, a human prescription drug labeled by Hf Acquisition Co. Llc, Dba Healthfirst. This injection, powder, for solution is formulated for intramuscular; intravenous use and contains methylprednisolone sodium succinate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hf Acquisition Co. Llc, Dba Healthfirst on September 02, 2018. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. Methylprednisolone is a corticosteroid hormone. This injectable form of methylprednisolone is used when a similar drug cannot be taken by mouth or when a very fast response is needed, especially in patients with severe medical conditions. Talk to your doctor about the risks and benefits of methylprednisolone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use. Methylprednisolone may also be used with other medications in hormone disorders.

How is this Hf Acquisition Co. Llc, Dba Healthfirst product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51662126403. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51662-1264-3
11-Digit CMS (5-4-2)
51662-1264-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.